2018
DOI: 10.3389/fpsyt.2018.00209
|View full text |Cite
|
Sign up to set email alerts
|

Blood-Based Lipidomics Approach to Evaluate Biomarkers Associated With Response to Olanzapine, Risperidone, and Quetiapine Treatment in Schizophrenia Patients

Abstract: This is the first study to identify lipidomic markers in plasma associated with response of acutely ill schizophrenia patients in response to specific antipsychotic treatments. The study population included 54 schizophrenia patients treated with antipsychotics for 6 weeks. Treatment led to significant improvement in positive and negative symptoms for 34 patients with little or no improvement for 20 patients. In addition, 37 patients showed an increase in body mass index after the 6 week treatment period, consi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
12
0
1

Year Published

2018
2018
2023
2023

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 24 publications
(13 citation statements)
references
References 39 publications
0
12
0
1
Order By: Relevance
“…Therefore, changes in lipids have been associated with the pathophysiology of schizophrenia. Specifically, alterations related to fatty acids and ketone bodies 55 , 56 , phospholipids 57 , 58 sphingolipids 59 , total lipids, triglycerides and cholesterol esters were observed in schizophrenia patients 60 62 .…”
Section: Resultsmentioning
confidence: 98%
“…Therefore, changes in lipids have been associated with the pathophysiology of schizophrenia. Specifically, alterations related to fatty acids and ketone bodies 55 , 56 , phospholipids 57 , 58 sphingolipids 59 , total lipids, triglycerides and cholesterol esters were observed in schizophrenia patients 60 62 .…”
Section: Resultsmentioning
confidence: 98%
“…Our study also identified lower PC lipids in the skeletal muscle of AAP-treated patients compared to mood stabilizer patients. Previous work has demonstrated that antipsychotics may have effects on peripheral blood and brain PC levels in humans [16,18,19,30,32,46]. Findings from these studies suggest that AAPs may increase peripheral PC levels following treatment compared to healthy controls, psychiatric controls or first-episode AAP- naïve patients.…”
Section: Discussionmentioning
confidence: 94%
“…In vivo studies in rodent models have demonstrated that some antipsychotics, but not all, increase the synthesis of peripheral and central nervous system polyunsaturated fatty acids [40]. This is supported by several peripheral blood lipidomic studies within humans that suggest antipsychotics alter, and often increase, most fatty acid species after treatment ranging from four to 12 weeks [18,19,30,41]. In contrast, Albaugh and colleagues demonstrated that short-term treatment with olanzapine, an AAP associated with a higher rate of insulin resistance and weight gain caused a reduction in free fatty acids within gastrocnemius muscle tissue, which may be supported by our findings here [42].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Moreover, given the side effects of antipsychotic medications, there has been a significant drop in medication usage by patients, which can only worsen the symptoms and, therefore, the mental health of the patients. Thus far, we were able to generate panels of lipid [11] and protein biomarkers [12], which may be implemented as biochemical tests for the prediction of a successful drug response. Proteomic signatures have also been used to build a diagnostic test for schizophrenia [13], which was even commercialized, but later discontinued.…”
mentioning
confidence: 99%